Main description:

Deprescribing and Polypharmacy in an Aging Population supports healthcare professionals across global healthcare institutions in reducing polypharmacy-related drug replated problems (DRPs) by working with patients, families, interprofessional healthcare professionals, and educational institutions to develop, implement, test, improve upon, and educate on strategies for deprescribing and optimizing patient safety. Polypharmacy, the use of multiple medications at the same time by one person, is very common in various patient populations, including those who lack primary physicians, patients with mental health conditions, patients with multiple chronic conditions, and in the aging population.

Contents:

1. Deprescribing Around the Globe
2. Deprescribing in Palliative Patients
3. Deprescribing in Alzheimer's Patients
4. Guidelines, Algorithms, and Emerging Evidence: Deprescribing as an Essential Part of Prescribing
5. Educating Young Professionals: Incorporation of Deprescribing into School Curriculums
6. Multidisciplinary Teams are Essential for Deprescribing
7. Case Studies: Risks of Polypharmacy and the Impact of Deprescribing on Quality of Life
8. Looking to the Future: Artificial Intelligence in Deprescribing
9. Challenges of Deprescribing During COVID-19
10. Implementation of Deprescribing in Institutions and Future Directions